John L Berk

24PUBLICATIONS
70CO-AUTHORS
Peripheral nervous systemGene and molecular therapyPanel data analysisNeurology and neuromuscular diseasesRespiratory diseases
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (24)

|Sep 04, 2026
Impact of Baseline Polyneuropathy Severity on Eplontersen Efficacy in the NEURO-TTRansform Clinical Trial.

|Jul 09, 2026
Guidelines for the management of hereditary ATTR amyloidosis 2026.

|Apr 06, 2026
Eplontersen for Hereditary Transthyretin Amyloidosis With Polyneuropathy: An Exploratory Analysis of Treatment Effect in Male and Female Patients.

Márcia Waddington Cruz, John L Berk, Yeşim Parman

|Mar 31, 2025
Changing Treatment Landscape in Transthyretin Cardiac Amyloidosis.

Marianna Fontana, John L Berk, Brian Drachman

|Nov 18, 2024
Estimating Meaningful Differences in Measures of Neuropathic Impairment, Health-Related Quality of Life, and Nutritional Status in Patients With Hereditary Transthyretin Amyloidosis.

Folke Folkvaljon, Morie Gertz, Julian D Gillmore

|Feb 07, 2024
Impact of vutrisiran on exploratory cardiac parameters in hereditary transthyretin-mediated amyloidosis with polyneuropathy.

Pablo Garcia-Pavia, Martha Grogan, Parag Kale

Pageof 4

Frequent Collaborators

7 joint publications

Vaishali Sanchorawala

5 joint publications

Lawreen H Connors

3 joint publications

Frederick L Ruberg

3 joint publications

Markus Weiler